Wang et al. [97] analyzed an LCNEC patient whose PD-L1 protein expression was negative, but the patient had a strong response to pembrolizumab, which brought new possibilities for the prognosis of LCNEC patients. The gene discussed is CD274; the disease is large cell neuroendocrine carcinoma.